EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that enrollment in its pivotal multicenter investigational device exemption (IDE) clinical study, the PARADIGM Trial (Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine), has concluded after the completion of 50…
Guardant Health announced that its blood-based colorectal cancer screening test Shield is now accessible nationwide through the testing network of…
A growing number of parents are investing in tests, supplements, and lifestyle programs designed to shape their babies’ gut microbiomes,…
Atlanta Gastroenterology Associates has agreed to pay $4.75 million to settle allegations that it violated the False Claims Act by…
The U.S. healthcare system is approaching a tipping point, driven by three converging threats: rising care costs, a growing chronic…
DDW 2026
Several studies presented at DDW 2026 highlighted emerging approaches that could reshape…
A structured triage system for interventional GI referrals changed the originally requested…
Thought Leadership
In this episode of The Scope Forward Show, Praveen Suthrum speaks with…
Rather than challenging the value of colonoscopy, Dr. Paul Limburg argues that…
Why Pathways Need Orchestration Before They Can Scale By Dr. Charles Accurso…
ARTIFICIAL INTELLIGENCE (AI)
Tech & Innovation
Video capsule endoscopy is no longer just a niche tool for evaluating small-bowel bleeding. In this expert review, Shabana F. Pasha, MD, explores the expanding role…